High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
In thalassemia, deficient globin-chain production during erythropoiesis results in anemia. Thalassemia may be further complicated by iron overload (frequently exacerbated by blood transfusion), which induces numerous endocrine diseases, hepatic cirrhosis, cardiac failure and even death. Accumulation of iron in the absence of blood transfusions may result from inappropriate suppression of the iron-regulating peptide hepcidin by an erythropoietic mechanism. To test this hypothesis, we examined erythroblast transcriptome profiles from 15 healthy, nonthalassemic donors. Growth differentiation factor 15 (GDF15), a member of the transforming growth factor-beta superfamily, showed increased expression and secretion during erythroblast maturation. Healthy volunteers had mean GDF15 serum concentrations of 450 +/- 50 pg/ml. In comparison, individuals with beta-thalassemia syndromes had elevated GDF15 serum levels (mean 66,000 +/- 9,600 pg/ml; range 4,800-248,000 pg/ml; P < 0.05) that were positively correlated with the levels of soluble transferrin receptor, erythropoietin and ferritin. Serum from thalassemia patients suppressed hepcidin mRNA expression in primary human hepatocytes, and depletion of GDF15 reversed hepcidin suppression. These results suggest that GDF15 overexpression arising from an expanded erythroid compartment contributes to iron overload in thalassemia syndromes by inhibiting hepcidin expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growth-differentiation factor (GDF)-15, whose levels are increased in thalassemia and AI with or without ID, also inhibits HAMP expression [60, 64].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“However, in being the primary iron source for erythropoiesis, TF also indirectly regulates HAMP expression via erythroid progenitor-derived mediators, suggesting that the pathways of HAMP regulation are interconnected [59–61].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“Growth differentiation factor 15 (GDF-15) and twisted gastrulation homolog 1 (TWSG1) have been identified as candidate erythrokines, although not erythroblast-specific, that have the potential to suppress hepcidin under conditions of increased erythropoietic activity.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“GDF15 is an iron- and O2-regulated (HIF-independent) member of the TGF-β superfamily, which is secreted from maturing erythroblasts and has been shown to suppress hepcidin transcription in primary human hepatocytes and hepatoma cells”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“This is in contrast to previous reports where higher doses of GDF15 were needed to achieve hepcidin suppression in human HuH-7 hepatoma cells and in primary hepatocytes, while low dose GDF15 treatment increased hepcidin.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Weatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,069
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundRund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
(1973) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 811
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756
Self-citationA role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundSelf-citationXu, J., Kimball, T. R., Lorenz, J. N., Brown, D. A., Bauskin, A. R., Klevitsky, R., Hewett, T. E., Breit, S. N., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000202804.84885.d0 · Cited by 506 · cited 1×
“Studies in cardiomyocytes suggest that GDF15 activates Smad2/3 signalin”
BackgroundLarge-Scale Delineation of Secreted Protein Biomarkers Overexpressed in Cancer Tissue and Serum
Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530278100 · Cited by 503 · cited 1×
“Elevated serum GDF15 concentrations have been reported in a variety of cancer”
BackgroundThe transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464
Cited by
Items 701–800 of 865
Hematological Findings in Non-Treated and γ-Irradiated Mice Deficient for MIC-1/GDF15
HOFER, M., Hoferová, Z., Remšík, J., Nováková, M., Procházková, J., Fedr, R., Kohoutek, J., Dušek, L., Hampl, A., & Souček, K. (2018) · Physiological Research · doi:10.33549/physiolres.933810 · Cited by 2
THE ROLE OF HEPCIDIN 25 IN THE DEVELOPMENT OF ANEMIC SYNDROME ASSOCIATED WITH MALIGNANT DISEASES
Назировна, Х. М., Владимирович, С. А., Blindar, V. N., Ryabchikov, D. A., Dobrovolskaya, M. M., Кононенко, И. Б., Kelemetov, A. M., Kazakov, A. M., & Palchinskaia, O. V. (2020) · Russian Journal of Biotherapy · doi:10.17650/1726-9784-2020-19-4-29-34 · Cited by 2
Al-Mamoori, H. S., & Yousif, M. H. (2022) · Iraqi Journal of Hematology · doi:10.4103/ijh.ijh_39_21 · Cited by 2
Anis, Z. M. A., Ahmed, A. Y., Soliman, H. H., & Nagy, H. M. (2022) · Tanta Medical Journal · doi:10.4103/tmj.tmj_173_20 · Cited by 2
Normal iron absorption and metabolism
Barton, J. C., Edwards, C. Q., Phatak, P. D., Britton, R. S., & Bacon, B. R. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777035.004 · Cited by 1
Sumera, A., Radhakrishnan, A. K., Cheong, S. K., & Baba, A. A. (2025) · Advances in Hematology · doi:10.1155/ah/2179600 · Cited by 2
“Te levels of GDF15 are increased in thalassemia [36], produced by erythroid progenitors, resulting in a decreased hepcidin secretion from the liver [35, 36].”
Manganas, K., Delicou, S., Hadziyannis, E. S., Giannouli, S., & Koskinas, J. S. (2025) · International Journal of Hematology · doi:10.1007/s12185-025-04035-8 · Cited by 1
“GDF-15 is known to suppress hepcidin, the key hormone regulating iron metabolism [9, 25].”
Fujiwara, T., & Harigae, H. (2025) · Molecular and Cellular Biology · doi:10.1080/10985549.2025.2553648 · Cited by 1
Yao, T., Zheng, P., Wang, Z.-N., Fang, L.-X., Wu, Y., & Lin, Y.-N. (2025) · Mediators of Inflammation · doi:10.1155/mi/1153091 · Cited by 1
“Tanno et al. [39] suggested that GDF-15 suppresses hepcidin secretion in hepatocytes, triggering cell apoptosis and thereby contributing to NAFLD progression.”
van der Minnen, L. M., Vendelbo, J. H., Pedersen, L. H., & Painter, R. C. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.12.060 · Cited by 1
González-Resina, R., de Valderrama, S. E. F., Montañés, Á., Recasens, V., & Caballero, G. (2026) · Annals of Hematology · doi:10.1007/s00277-026-06774-y · Cited by 1
“Altered regulation of the hepcidin-iron axis has been implicated in this process [3, 9 ], and our showing higher age averages ( p = 0.003).”
InfluentialErythroferrone in β-thalassemia: Systematic review and meta-analysis
Saboor, M., & Abass, K. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121179 · Cited by 1
Iron and Copper Metabolism in the Myelodysplastic Syndromes
Várkonyi, J., Bekő, G., Prohászka, Z., & Karádi, I. (2011) · Springer eBooks · doi:10.1007/978-94-007-0440-4_11 · Cited by 1
“(GDF-15) was identified as a candidate for one of the erythroid factors suppressing hepcidin [ 24 ].”
BackgroundNinth Cooley's Anemia Symposium: summary and perspective
Nienhuis, A. W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05549.x · Cited by 1
Vecchi, C., & Pietrangelo, A. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch29 · Cited by 1
Évaluation des performances analytiques d’une méthode Elisa pour le dosage du GDF-15 plasmatique
Mauge, L., Paul, J. L., & Benoit, M. O. (2010) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/j.immbio.2010.01.004 · Cited by 1
Fer, hepcidine et insuffisance rénale chronique
Fievet, P., & Brazier, F. (2010) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2010.10.011 · Cited by 2
Gay, J., Fournier, M., Pierre‐Eugène, C., Fontenay, M., Charpentier, A., Mayeux, P., Pissard, S., Costa, L. M. D., Beaumont, C., & Rosé, C. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08932.x · Cited by 1
Iron metabolism in chronic kidney disease
Małyszko, J., & Macdougall, I. C. (2015) · Oxford University Press eBooks · doi:10.1093/med/9780199592548.003.0125 · Cited by 1
Cellular and Systemic Iron Homeostasis
Crichton, R. R. (2016) · Wiley eBooks · doi:10.1002/9781118925645.ch10 · Cited by 2
Новые подходы к лечению анемии хронических заболеваний
Будневский, А. В., Сергеевич, О. Е., Воронина, Е. В., Лабжания, Н. Б., & Жусина, Ю. Г. (2018) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/0031-2991.2018.03.106-112 · Cited by 1
Kashfi, S. M., Sharifi, E. M., Rakhshani, T., & Hosseini, S. S. (2018) · Journal of Human Environment and Health Promotion · doi:10.29252/jhehp.4.3.4 · Cited by 1
“However, if two individuals with thalassemia minor are married, 25% of their children are expected to have thalassemia major, while 25% of their children will be normal, and 50% will have thalassemia minor [2-4].”
BackgroundZhang, L., Wang, Y., Jin, H., Wang, D., Wei, L., Ren, K., & Mao, Y. (2019) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2019.10.04 · Cited by 1
Growth-differentiation factor-15 expression in anemia of chronic disease and iron-deficiency anemia
Abdullah, N., & Ahmed, A. (2020) · Iraqi Journal of Hematology · doi:10.4103/ijh.ijh_7_20 · Cited by 1
Al-Barshomy, S. M., Zedan, A., & Mostafa, M. E. (2021) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2021.156448 · Cited by 2
“Alternatively, EPO administration may indirectly lead to suppression of hepcidin via increased levels of growth differentiation factor-15, which is secreted by erythroblasts (33) or via the molecule named twisted gastrulation (TWSG1).”
BackgroundFe Deficiency, Dietary Bioavailability and Absorption
Tako, E. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-231-0 · Cited by 2
Pietrangelo, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00060-4 · Cited by 2
Tata Laksana Terkini Talasemia ?: Terapi Target
Susanah, S. (2022) · Sari Pediatri · doi:10.14238/sp24.4.2022.279-85 · Cited by 5
Pietrangelo, A., & Torbenson, M. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00004-1 · Cited by 1
A deep dive into future therapies for microcytic anemias and clinical considerations
Rodrigues, F., Coman, T., Fouquet, G., Côté, F., Courtois, G., Maciel, T. T., & Hermine, O. (2023) · Expert Review of Hematology · doi:10.1080/17474086.2023.2206556 · Cited by 1
“They are secreted by erythroblasts and repress Hamp expression by modulation of SMAD signaling [50,51].”
BackgroundA review on herbal drugs used in thalassemia and related disorder
Tilva, T., & Jethwa, V. (2022) · Journal of Medicinal Plants Studies · doi:10.22271/plants.2022.v10.i6b.1500 · Cited by 1
Wang, X., Lipiński, P., Ogłuszka, M., Mazgaj, R., Woliński, J., Szkopek, D., Zaworski, K., Kopeć, Z., Żelazowska, B., Tarantino, G., et al. (2025) · Food & Function · doi:10.1039/d4fo04806g · Cited by 1
Classical and atypical HFE hemochromatosis
Barton, J. C., Edwards, C. Q., Phatak, P. D., Britton, R. S., & Bacon, B. R. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777035.010 · Cited by 1
[Hepcidin for iron homeostasis and target therapy in ironrelated disorders].
Fan, S., Zheng, Y., & Shi, J. (2015) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2015.11.020 · Cited by 1
“[18] Tanno T, Bhanu NV, Oneal PA, et al.”
BackgroundGattermann, N., & Rosé, C. (2018) · Hematologic malignancies · doi:10.1007/978-3-319-76879-3_8 · Cited by 1
Post-transcriptional regulation of HFE gene expression
Martins, R. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 2
Identification and analysis of genetic and chemical modulators of iron metabolism
Hawula, Z. J. (2021) · Queensland University of Technology · doi:10.5204/thesis.eprints.225904 · Cited by 1
TGF-b Superfamily Cytokine MIC-1/GDF15 in Health and Inflammatory Diseases
Breit, S. N., & Brown, D. A. (2014) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_54-1 · Cited by 1
Crosstalk Between Iron and Bone Metabolism: Evidence from Patients and Mouse Models of β-Thalassemia
Castro-Mollo, M. W., Feola, M., & Ginzburg, Y. Z. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11557-0 · Cited by 1
Hereditary sideroblastic anemias
Barton, J. C., Edwards, C. Q., Phatak, P. D., Britton, R. S., & Bacon, B. R. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777035.027
Evangelista, A. S. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2013.tde-01082013-134115 · Cited by 1
Organ damage and iron overload
Angelucci, E., Cogoni, C., Pettinau, M., Pilo, F., Targhetta, C., & Zaccheddu, F. (2009) · Hematology Meeting Reports (formerly Haematologica Reports) · doi:10.4081/hmr.v2i5.718
Iron Homeostasis: Hepcidin Regulation
Camaschella, C., & Silvestri, L. (2004) · Wiley eBooks · doi:10.1002/9781119951438.eibc2131
Iron overload associated with hemoglobinopathies
Barton, J. C., Edwards, C. Q., Phatak, P. D., Britton, R. S., & Bacon, B. R. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777035.024
The role of haem transport and iron chelation in oesophageal cancer
Ford, S. (2013) · University of Birmingham Institutional Research Archive (University of Birmingham)
Avaliação da expressão de hepcidina e produção de IL-6 por monócitos de indivíduos idosos
Miranda, J. C. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.60.2009.tde-25082009-152450 · Cited by 1
Non-transferrin-bound iron in hematopoietic stem cell transplantation
Sahlstedt, L. (2015) · Helda - University of Helsinki Institutional Repository
Ilkovska, B., Trifunova, B. K., & Трифунов, Г. (2015) · e-Letras com Vida Revista de Estudos Globais — Humanidades Ciências e Artes · doi:10.3889/mmej.2015.50010
“Во оваа конкретнa подгрупа на пациенти, раст на факторот 15 на диференцијација, се смета како сигнал на коскена срцевина кој предизвикува супресија на хепцидинот [105].”
Pfeilstöcker, M. (2010) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-010-0179-6
“Serum from thalassemia patients suppressed hepcidin mRNA expression in primary human hepatocytes, and depletion of GDF15 reversed hepcidin suppression suggesting that GDF15 overexpression arising from an expanded erythroid compartment contributes to iron overload in thalassemia syndromes by inhibiting hepcidin express…”
BackgroundEnfermedades por sobrecarga de hierro en los niños
Brissot, P., Bardou‐Jacquet, E., Latournerie, M., Bridoux‐Henno, L., Jouanolle, A., & Loréal, O. (2013) · EMC - Pediatría · doi:10.1016/s1245-1789(13)64496-0
Fer et inflammation, mariage impossible ?
Lasocki, S. (2012) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2012.01.001
Brissot, P., Latournerie, M., Bardou‐Jacquet, E., Loréal, O., Jouanolle, A., & Deugnier, Y. (2011) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(11)54630-7
GDF15 (growth differentiation factor 15)
Senapati, S., Singh, A., & Batra, S. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44426
Kawabata, H. (2009)
Anemia and response to erythropoietin in the cardiorenal syndrome
van der Putten, K. (2011) · Utrecht University Repository (Utrecht University)
Hepcidin : analysis, regulation and clinical perspectives
Kemna, E. (2008) · Radboud Repository (Radboud University)
Regulation of hepcidin and hemojuvelin expression and their role in iron homeostasis
Salama, M. (2010) · UCL Discovery (University College London)
Iron: Molecular Basis of Hemochromatosis
Schmidt, P. J. (2004) · Wiley eBooks · doi:10.1002/9781119951438.eibc2137
The regulation of human iron metabolism in hypoxia
Govus, A. D. (2015) · Research Online (Edith Cowan University)
IRON OVERLOAD: CAUSES, CONSEQUENCES, AND CONTROL
Bentley, D. P. (2014) · DOAJ (DOAJ: Directory of Open Access Journals)
Ginzburg, Y. Z., & Rivella, S. (2012)
Iron transport and liver injury in mouse models of hereditary haemochromatosis
De Lima, R. (2013) · UWA Profiles and Research Repository (University of Western Australia)
Oxygen-Dependent Regulation of Erythropoiesis
Haase, V. H. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_23
NEW APPROACHES TO THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIA
Steinberg, M. H., Forget, B. G., Higgs, D. R., & Weatherall, D. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.039
2. Iron Metabolism and Iron Overload.
Kohgo, Y. (2011) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.100.2412
White, J. A. (2015) · Journal of Cancer Prevention & Current Research · doi:10.15406/jcpcr.2015.03.00077 · Cited by 1
“Erythrokine, however, is thought to supress hepcidin mRNA in vitro [50].”
BackgroundInfluentialCongenital Dyserythropoietic Anemia type III (CDA III) : diagnostics, genetics and morbidity
Liljeholm, M. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Hypoxia-Dependent Hepcidin Down-Regulation: In Vitro and In Vivo Studies
Ravasi, G. (2016) · BOA (University of Milano-Bicocca)
Alterações do metabolismo do ferro nas talassemias
Guimarães, J. D. S. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2014.tde-17042015-113612
Iron overload associated with thalassemia syndromes
Barton, J. C., Edwards, C. Q., Phatak, P. D., Britton, R. S., & Bacon, B. R. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777035.023
ヘプシジン‐25と骨髄造血機能―第54回日本透析医学会シンポジウムより―
Tomosugi, N. (2009) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.42.821
Tandara, L. (2016) · Repozitorij Farmaceutsko-biokemijskog fakulteta (Sveučilišta u Zagrebu)
Kahli, A. (2016) · theses.fr (ABES) · doi:10.70675/a208a380z8413z4579z852fza5467418d8b9 · Cited by 1
“Cependant, la surexpression du GDF-15, peut conduire à une augmentation du risque de développer différentes pathologies, telles que les thalassémies et autres anémies dysérythropoïétiques congénitales [345, 346].”
BackgroundMolecular and clinical factors affecting myocardial iron retention in transfusional haemosiderosis
Garbowski, M. (2017) · UCL Discovery (University College London) · Cited by 1
Carli, E. D. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2017.tde-26012017-123209
Hemochromatosis and Iron Storage Disorders
Kowdley, K. V., & Handa, P. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch30
Multiple Modes of Hepcidin Regulation in Breast Cancer
Farra, N. (2017) · OpenCommons - UConn (University of Connecticut) · Cited by 1
Gudjoncik, A. (2015) · theses.fr (ABES) · doi:10.70675/21bb98a6z77b6z47d5zbd3ezc62b17e21e10 · Cited by 2
“GDF-15 réprime la sécrétion d'hepcidine [111,112].”
BackgroundAdvances in iron homeostasis and ferromagnetic nanoparticles
Wang, J., An, P., Wang, H., Wu, Q., Fang, X., Min, J., & Wang, F. (2018) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972018-00707
Velaga, R. M. (2014) · London Met Repository (London Metropolitan University) · Cited by 1
Laboratory Assessment of Iron Status
Brugnara, C. (2019) · Cambridge University Press eBooks · doi:10.1017/9781139023993.006 · Cited by 1
The Role of Erythropoiesis on Hepcidin Level in Polytransfused b-Thalassemia Major Patients
EL-SALAM, M. D. M. T. E. M. N., EL-TAHTAWY, M. D. T. K. E.-D. M. Y., MOHAMMED, M. D. M. M. E. W. S., & NASIF, M. D. E. M. E.-G. K. A. (2018) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2018.60589
MEABED, M. D. A. S. S. M. H., EZZAT, M. D. S. S. A.-E. D. A., & Eldahshan, D. H. (2019) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2019.69931 · Cited by 2
“Tanno et al., reported that individuals with β - thalassemia have elevated serum GDF15 levels which are positively correlated with sTfR, erythropoietin (EPO), and Serum Ferritin (SF) levels and negatively associated with hemoglobin levels [29] Tanno et al., 2007.”
BackgroundThe role of hepcidin in iron metabolism in athletes
Bajić, Z., Ponorac, N., & Matavulj, A. (2019) · Fizicka kultura · doi:10.5937/fizkul1902206b
Milenković, J., Stojanović, D. R., & Najdanović, J. G. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94081
Shehryar, M., Aslam, M., Sohail, N., Qadeer, S., & Tariq, T. (2020) · Pakistan BioMedical Journal · doi:10.52229/pbmj.v2i2.17
Iron Loading and Chelation in Non-transfusion Dependent Thalassemias
Ünal, Ş. (2015) · Acta Medica
A vasanyagcsere szabályozása, hepcidinexpresszió fiziológiás és pathológiás körülmények között
Egyed, M. (2021) · Hematológia–Transzfuziológia · doi:10.1556/2068.2021.54.1.6 · Cited by 1
Sanyear, C., Chiawtada, B., Butthep, P., Svasti, S., Fucharoen, S., & Masaratana, P. (2021) · PeerJ · doi:10.7717/peerj.11367
“…erythropoiesis, erythroid regulators of hepcidin, namely growth differentiation factor 15 (GDF15), twisted gastrulation 1 (TWSG1), and particularly erythroferrone (ERFE), are released from erythroid precursor cells leading to hepcidin suppression (Tanno et al., 2007, 2009; Kautz et al., 2014).”
Self-citationImpact of the UPR on the expression of relevant genes for cellular iron metabolism
Oliveira, S. J. (2011)
Standing up for Lindsay Anderson (Review article)
Neve, B. (2002) · Cinéaste/Cinéaste
Yaseen, A. K., Abbas, S. S., & Abdulhadi, A. M. A. (2019) · Iraqi journal of Medical Sciences · doi:10.22578/ijms.17.1.10
Schuff‐Werner, P. (2010) · Springer eBooks · doi:10.1007/978-3-642-12765-6_9
Hereditary anemias: more complex than ever
van Vuren, A. J. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/429
Holden, H. (2011) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2011-06791
Metadata
- Authors
- Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., Eling, T. E., Childs, R., Ganz, T., Leitman, S. F., Fucharoen, S., & Miller, J. L.
- Affiliations
- National Institutes of Health (US)
- Walter Reed National Military Medical Center (US)
- Children's National (US)
- University of California, Los Angeles (US)
- Mahidol University (TH)
- Corresponding author
- Miller, Jeffery L
- Venue
- Nature Medicine
- Published
- 2007-08-26
- Volume
- 13
- Issue
- 9
- Pages
- 1096-1101
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2107423980
- Cited by
- 854
- References
- 32
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 15 · 2023: 26 · 2022: 27 · 2021: 52 · 2020: 40 · 2019: 37 · 2018: 44 · 2017: 45 · 2016: 47 · 2015: 55 · 2014: 55 · 2013: 54 · 2012: 53
- FWCI
- 40.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Keywords
- GDF15, growth differentiation factor 15, beta-thalassemia, hepcidin, iron overload, erythropoiesis, erythroblasts, soluble transferrin receptor, ferritin, erythropoietin, hepatocytes, iron regulation
- MeSH terms
- Gene Expression Regulation, Humans, Reference Values, RNA, Messenger, Thalassemia, Transcription, Genetic, Polymerase Chain Reaction, Cytokines, Gene Expression Profiling, Antimicrobial Cationic Peptides, Growth Differentiation Factor 15, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.